177 related articles for article (PubMed ID: 18076562)
1. Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004.
Vega JC; Sanchez BF; Montero LM; Montaña R; Del Pilar Mahecha M; Dueñes B; Baron AR; Reithinger R
Trop Med Int Health; 2007 Dec; 12(12):1540-4. PubMed ID: 18076562
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting.
Vega JC; Sanchez BF; Montero LM; Montaña R; Mahecha Mdel P; Dueñes B; Baron AR; Reithinger R
Trans R Soc Trop Med Hyg; 2009 Jul; 103(7):703-6. PubMed ID: 19059616
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia.
Cardona-Arias JA; López-Carvajal L; Tamayo-Plata MP; Vélez ID
BMC Public Health; 2018 Jan; 18(1):185. PubMed ID: 29378537
[TBL] [Abstract][Full Text] [Related]
4. Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
Soto J; Toledo J; Vega J; Berman J
Am J Trop Med Hyg; 2005 Apr; 72(4):421-2. PubMed ID: 15827279
[TBL] [Abstract][Full Text] [Related]
5. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous leishmaniasis].
Vion B
Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
[No Abstract] [Full Text] [Related]
7. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
[TBL] [Abstract][Full Text] [Related]
9. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
Tachfouti N; Najdi A; Alonso S; Sicuri E; Laamrani El Idrissi A; Nejjari C; Picado A
PLoS One; 2016; 11(6):e0155482. PubMed ID: 27257808
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.
Berger BA; Cossio A; Saravia NG; Castro MDM; Prada S; Bartlett AH; Pho MT
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005459. PubMed ID: 28384261
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice.
Delgado O; Silva S; Coraspe V; Rivas MA; Rodriguez-Morales AJ; Navarro P; Franco-Paredes C
Travel Med Infect Dis; 2008 Nov; 6(6):376-9. PubMed ID: 18984484
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.
Olliaro P; Darley S; Laxminarayan R; Sundar S
Trop Med Int Health; 2009 Aug; 14(8):918-25. PubMed ID: 19563434
[TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis in clinical practice.
Davidson RN
J Infect; 1999 Sep; 39(2):112-6. PubMed ID: 10609527
[No Abstract] [Full Text] [Related]
14. [Treatment of cutaneous leishmaniasis].
Lambert D; Mambre B
Ann Dermatol Venereol; 1988; 115(5):641-3. PubMed ID: 3058010
[No Abstract] [Full Text] [Related]
15. [Current situation and future of antileishmanial therapy in Colombia].
Soto J; Soto P
Biomedica; 2006 Oct; 26 Suppl 1():194-206. PubMed ID: 17361855
[TBL] [Abstract][Full Text] [Related]
16. Drug regimens for visceral leishmaniasis in Mediterranean countries.
Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
[TBL] [Abstract][Full Text] [Related]
17. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
Sadeghian G; Nilfroushzadeh MA; Iraji F
Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
[TBL] [Abstract][Full Text] [Related]
19. Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting.
Reithinger R; Coleman PG
BMC Infect Dis; 2007 Jan; 7():3. PubMed ID: 17263879
[TBL] [Abstract][Full Text] [Related]
20. Use of meglumine antimoniate in canine leishmaniasis.
Lamothe J
Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
[No Abstract] [Full Text] [Related]
[Next] [New Search]